4 stories mentioning CTX.TOUpdated 27d ago
Every FINWIRES story that references CTX.TO, newest first.
Crescita Therapeutics (CTX.TO) shareholders will receive $0.80 per share under the transaction with ClinActiv Holdings, the company confirmed on Tuesday.The arrangement is expected to be completed on June 3, after which Crescita shares will be delisted from the Toronto Stock Exchange.Crescita shares last traded on May 28, closing at $0.75.
Crescita Therapeutics (CTX.TO) on Monday said its first-quarter loss widened even as revenue advanced.The company, which being acquired by ClinActiv Holdings, said its first-quarter loss widened to $1.2 million, or $0.06 per share, from a loss of $0.7 million, or $0.05 per share, in the prior-year period.Revenue rose to $5.64 million from $3.54 million a year earlier. The rise of $2.1 million was primarily driven by higher manufacturing segment revenue of $1.6 million, mainly due to the fulfillment of large orders during the quarter. Skincare sales also increased by $592,000, mainly reflecting incremental revenue from Bacti Control, acquired last August."During the first quarter, we continued to execute against our operational priorities. Our results reflect the year-over-year revenue and gross profit growth, driven by higher production volumes in our Manufacturing segment as well as the incremental revenue from recently acquired skincare assets," said chief executive Serge Verreault.Crescita Therapeutics was last seen unchanged at $0.76, on the Toronto Stock Exchange.
